Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Wed Apr 02 10:41:21 GMT 2025
by
admin
on
Wed Apr 02 10:41:21 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | HUMAN |
| Source Materials Parent | |
| Part | blood plasma |
| Fraction Material Type | protein |
| Fraction Name | igg |
| Record UNII |
VF62JD6WN3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
VF62JD6WN3
Created by
admin on Wed Apr 02 10:41:21 GMT 2025 , Edited by admin on Wed Apr 02 10:41:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| TARGETED ANTIGEN | IMMUNOLOGICAL |
|
SARS-COV2 | B6L4N5Z4GH |